Related Experiment Videos
Long-term juxtafoveal retinal telangiectasia
Robert C Watzke1, Michael L Klein, James C Folk
1Casey Eye Institute, Oregon Health & Science University, Portland, Oregon 97239-4197, USA. watzker@ohsu.edu
Retina (Philadelphia, Pa.)
|September 6, 2005
Summary
Idiopathic juxtafoveal telangiectasia (IJRT) often leads to vision loss, particularly in untreated eyes. The long-term prognosis for central vision in IJRT patients is generally poor, varying by disease type.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Vascular Retinopathies
Background:
- Idiopathic juxtafoveal telangiectasia (IJRT) is a rare retinal vascular disorder.
- Understanding the long-term progression of IJRT is crucial for patient management.
Purpose of the Study:
- To determine the long-term natural history of idiopathic juxtafoveal telangiectasia (IJRT).
Main Methods:
- Retrospective record review of patients diagnosed with IJRT between 1980 and 1993.
- Follow-up examinations and fluorescein angiography (FA) were conducted on identified patients.
- Analysis of visual acuity and morphological changes over an average of 15 years.
Main Results:
- Twenty patients (32 eyes) with IJRT were followed for 10-21 years.
- Twenty-four of 26 untreated eyes experienced vision loss.
- IJRT type IA showed vision loss in 6/8 untreated eyes; type IIA developed neovascularization in 15/20 untreated eyes.
Conclusions:
- The long-term prognosis for central vision in idiopathic juxtafoveal telangiectasia is poor.
- Prognosis is significantly influenced by the specific type and clinical features of IJRT.